Accessibility Menu
Surrozen logo

Surrozen

(NASDAQ) SRZN

Current Price$26.50
Market Cap$228.26M
Since IPO (2021)-82%
5 Year-82%
1 Year+135%
1 Month+9%

Surrozen Financials at a Glance

Market Cap

$228.26M

Revenue (TTM)

$3.60M

Net Income (TTM)

$86.91M

EPS (TTM)

$-21.83

P/E Ratio

-1.22

Dividend

$0.00

Beta (Volatility)

0.65 (Low)

Price

$26.50

Volume

1,657

Open

$25.85

Previous Close

$26.50

Daily Range

$25.03 - $26.50

52-Week Range

$5.90 - $29.59

SRZN News

SRZN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Surrozen

Industry

Biotechnology

Employees

41

CEO

Craig C. Parker, MBA

Headquarters

South San Francisco, CA 94080, US

SRZN Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-11%

Net Income Margin

-24%

Return on Equity

-130%

Return on Capital

-43%

Return on Assets

-92%

Earnings Yield

-81.97%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$228.26M

Shares Outstanding

8.57M

Volume

1.66K

Short Interest

0.00%

Avg. Volume

103.66K

Financials (TTM)

Gross Profit

$10.65M

Operating Income

$25.54M

EBITDA

$24.10M

Operating Cash Flow

$17.63M

Capital Expenditure

$26.00K

Free Cash Flow

$17.65M

Cash & ST Invst.

$34.56M

Total Debt

$8.47M

Surrozen Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$983.00K

-90.2%

Gross Profit

$983.00K

-90.2%

Gross Margin

100.00%

N/A

Market Cap

$228.26M

N/A

Market Cap/Employee

$5.71M

N/A

Employees

40

N/A

Net Income

$71.64M

-4896.0%

EBITDA

$71.58M

-4647.8%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$74.25M

+151.8%

Accounts Receivable

$2.57M

-78.9%

Inventory

$0.00

N/A

Long Term Debt

$5.84M

N/A

Short Term Debt

$1.24M

-18.5%

Return on Assets

-92.41%

N/A

Return on Invested Capital

-43.47%

N/A

Free Cash Flow

$9.06M

-34.2%

Operating Cash Flow

$9.04M

-33.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AGENAgenus Inc.
$3.81+1.33%
IRDOpus Genetics, Inc.
$4.58-1.72%
GLSIGreenwich LifeSciences, Inc.
$25.88-3.11%
SEERSeer, Inc.
$1.73-0.86%

Trending Stocks

Symbol / CompanyPricePrice Chg
ITUBItaú Unibanco
$8.12+0.01%
MUMicron Technology
$444.59-0.04%
RIVNRivian Automotive
$16.11+0.04%
TAT&T
$27.76+0.01%

Questions About SRZN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.